-
-
[1]PetersMG .Animalmodelsofautoimmuneliverdisease[J].ImmunolCellBoil, 2002, 80 (1) ∶113-116. [2]LeonardiS , PavoneP , RotoloN , etal.Autoimmunehepatitisassociatedwithceliacdiseaseinchildhood:Reportoftwocases[J].JGastroenterolHepatol, 2003, 18 (11) ∶1324-1327. [3]CzajaAJ.Uderstandingthepathogenesisofautoimmunehepatitis[J].AmJGastroenterol, 2001, 6 (4) ∶419-437. [4]RoseNR .Fundamentalconceptsofautoimmunityandautoimmunedisease[M].InKrawittEL , WiesnerRH , NishiokaM , eds.Autoimmuneliverdiseases, 2 nded.NewYork:ElsevierSciencePublishers, 1998∶1-20. [5]CzajaAJ.Immunopathogenesisofautoimmune-mediatedliverdamage[M].In:Moreno-OteroR , Clemente-RicoteG , GarciaMonzonC , eds.Immunologyandtheliver;Autoimmunity.Mardrid:AranEdi ciones, 2000∶73-83. [6]MannsMP , GriffinKJ, SullivanKF , etal.LKM -1autoantibodiesrec ognizeashortlinearsequenceinP450ⅡD6, acytochromeP -450monooxygenase[J].JClinInvest, 1991, 88 (4) ∶1370-1378. [7]KerkarN , ChoudhuriK , MaY , etal.CytochromeP4502d6 (193-212) :anewimmunodominantepitopeandtargetofvirus/selfcross-re activityinliverkedneymicrosomalautoantibodytype1-positiveliverdisease[J].JImmunol, 2003, 170 (3) ∶1481-1489. [8]KammerAR , vanderBurgSH , GrabscheidB , etal.MolecularmimicryofhumancytochromeP450byhepattitisCvirusatthelevelofcytotoxicTcellrecognition[J].JExpMed, 1999, 190 (2) ∶169-176. [9]PorallaT , TreichelU , LohrH , etal.Theasialoglycoproteinreceptorastargetstuctureinautoimmuneliverdiseases[J].SeminLiverDis, 1991, 11 (3) ∶215-222. [10]MannsMP , Obermayer-StraubP .CytochromesP450anduridinetriphosphate-glucuronosyltransferases:Modelautoantigenstostudydrug-induced, virus-induced, andautoimmuneliverdisease[J].Hepatolo gy, 1997, 26 (4) ∶1054-1066. [11]Wesierska-GadekJ, GrimmR , HitchmanE , etal.MembersoftheglutathioneS -transferasegenefamilyareantigensinautoimmunehepati tis[J].Gastronenterology, 1998, 114 (2) ∶329-335. [12]LapierreP , HajouiO , HombergJ -H , etal.Formiminotransferasecy clodeaminaseinanorgan-specificautoantigenrecognizedbyseraofpa tientswithautoimmunehepatitis[J].Gastroenterology, 1999, 116 (3) ∶643-649. [13]PelliN , FensomAH , SladeC , etal.Argininosuccinatelyase:Anewautoantigeninliverdisease[J].ClinExpImmunol, 1998, 114 (3) ∶455-461. [14]WiesI, BrunnerS , HenningerJ, etal.IdentificationoftargetantigenforSLA/LPautoantibodiesinautoimmunehepatitis[J].Lancet, 2000, 355 (9214) ∶1510-1515. [15]StrettellMDJ, DonaldsonPT , ThomsonLJ, etal.AllelicbasisforHLA-encodedsusceptibilitytotype1autoimmunehepatitis[J].Gastroenterology, 1997, 112 (6) ∶2028-2035. [16]CzajaAJ, StrettellMDJ, ThomosonLJ, etal.Associationsbetweenal lelesofthemajorhistocompatibilitycomplexandtype1autoimmunehep atitis[J].Hepatology, 1997, 25 (2) ∶317-323. [17]PandoM , LarribaJ, FernandezGC , etal.PediatricandadultformsoftypeⅠautoimmunehepatitisinArgentina:Evidencefordifferentialge neticpredisposition[J].Hepatology, 1999, 30 (6) ∶1374-1380. [18]Vazqueez-GarciaMN , AlazeC , OlivoA , etal.MHCclassⅡse quenceofsusceptibilityandprotectioninMexicanswithautoimmunehep atitis[J].JHepatol, 1998, 28 (6) ∶985-990. [19]CzajaAJ , KrugerM , SantrachPJ, etal.Geneticdistinctionsbetweentype1and2autoimmunehepatitis[J].Hepatology, 1997, 92 (12) ∶2197-2200. [20]CzajaAJ, RakelaJ, HayJE , etal.ClinicalandprognosticimplicationsofhumanleukocyteantigenB8incorticosteroid-treatedsevereautoim munechronicactivehepatitis[J].Gastroenterology, 1990, 98 (6) ∶1587-1593. [21]ManabeK , HibberdML , DonaldsonPT , etal.T -cellreceptorcon stantβgermlinepolymorphismsandsusceptibilitytoautoimmunehepatitis[J].Gastroenterology, 1994, 106 (5) ∶1321-1325. [22]McCoyKD , LeGrosG .TheroleofCTLA -4intheregulationofTcellimmuneresponses[J].ImmunolCellBiol, 1999, 77 (1) ∶1-10. [23]AgarwalK , JonesDE , DalyAK , etal.CytotoxicTlymphocyteantigen-4 (CTLA -4) genepolymorphismsandsusceptibilitytotype1autoim munehepatitis[J].Hepatology, 2000, 31 (1) ∶49-53. [24]TakeuchiF , KawasugiK , NabetaH , etal.AssociationofCTLA -4withsystemicsclerosisinJapanesepatients[J].ClinExpRheumatol, 2002, 20 (6) ∶823-828. [25]AgarwalK , JonesDE , DalyAK , etal.CTLA -4genepolymorphismconferssusceptibilitytoprimarybiliarycirrhosis[J].JHepatol.2000, 32 (4) ∶538-541. [26]ChistiakovDA , TurakulovRI.CTLA -4anditsroleinautoimmunethyroiddisease[J].JMolEndocrinol, 2003, 31 (1) ∶21-36. [27]DonnerH , RauH , WalfishPG , etal.CTLA -4alanine-17confersgeneticsusceptibilitytoGraves’Diseaseandtotype1diabetesmellitus[J].JClinEndocrinolMetab, 1997, 82 (1) ∶143-146. [28]CzajaAJ, SieversC , ZeinNN .Natureandbehaviorofimmunoregulato rycytokinesintype1autoimmunehepatitis[J].Gastroenterology, 1999, 116∶A1199. [29]CzajaAJ, CooksonS , ConstantiniPK , etal.Cytokinepolymorphismsassociatedwithclinicalfeaturesandtreatmentoutcomeintype1autoim munehepatitis[J].Gastroenterology, 1999, 177 (3) ∶645-652. [30]LuceyDR , ClericiM , ShearerGM .Type1andtype2cytokinedysreg ulationinhumaninfectious, neoplastic, andinflammatorydiseases[J].ClinMicrobiolRev, 1996, 9 (4) ∶532-562. [31]范列英, 仲人前, 屠小卿等.肿瘤坏死因子α基因多态性与中国人自身免疫肝病相关性研究[J].中华肝脏病杂志, 2004, 12 (3) ∶160-162. [32]VogelA , StrassburgCP , MannsMP .GeneticassociationofvitaminDreceptorpolymorphismswithprimarybiliarycirrhosisandautoimmunehepatitis[J].Hepatology, 2002, 35 (1) ∶126-131. [33]范列英, 仲人前, 屠小卿等.维生素D受体基因多态性与中国人自身免疫性肝病相关性研究[J].中华医学杂志, 2003, 83 (21) ∶1852-1855. [34]FaubionWA , GoresGJ .Deathreceptorsinliverbiologyandpathobiolo gy[J].Hepatology, 1999, 29 (1) ∶1-4. [35]VaishnawAK , McNallyJD , ElkonKB .Apoptosisintherheumaticdis eases[J].ArthritisRheum, 1997, 40 (11) ∶1917-1927. [36]OhsakoS , ElkonKB .Apoptosisintheeffectorphaseofautoimmunedi abetes, multiplesclerosisandthyroiditis[J].CellDeathDifferentiation, 1999, 6 (1) ∶13-21.
本文二维码
计量
- 文章访问数: 1978
- HTML全文浏览量: 10
- PDF下载量: 844
- 被引次数: 0